Innate immune receptors: Key regulators of metabolic disease progression

Cell Metabolism

Volumn 17, Issue 6, 2013, Pages 873-882

  Jin, Chengcheng ^a   Henao Mejia, Jorge ^a   Flavell, Richard A ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; MEMBRANE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADAPTIVE IMMUNITY; ATHEROSCLEROSIS; CYTOKINE RELEASE; GENE DELETION; HUMAN; INNATE IMMUNITY; INSULIN RESISTANCE; INTESTINE FLORA; LIPID PEROXIDATION; LIPID STORAGE; LIPOLYSIS; METABOLIC DISORDER; METABOLIC STRESS; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ATHEROSCLEROSIS; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FATTY LIVER; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INSULIN RESISTANCE; INTESTINES; METABOLIC DISEASES; OBESITY; RECEPTORS, IMMUNOLOGIC;

EID: 84878812591     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2013.05.011     Document Type: Review

References (107)

1. J. Amar, C. Chabo, A. Waget, P. Klopp, C. Vachoux, L.G. Bermúdez-Humarán, N. Smirnova, M. Bergé, T. Sulpice, and S. Lahtinen Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment EMBO Mol. Med. 3 2011 559 572
2. B.F. Belgardt, J. Mauer, F.T. Wunderlich, M.B. Ernst, M. Pal, G. Spohn, H.S. Brönneke, S. Brodesser, B. Hampel, A.C. Schauss, and J.C. Brüning Hypothalamic and pituitary c-Jun N-terminal kinase 1 signaling coordinately regulates glucose metabolism Proc. Natl. Acad. Sci. USA 107 2010 6028 6033
3. A. Biswas, and K.S. Kobayashi Regulation of intestinal microbiota by the NLR protein family Int. Immunol. 25 2013 207 214
4. H. Björkbacka, V.V. Kunjathoor, K.J. Moore, S. Koehn, C.M. Ordija, M.A. Lee, T. Means, K. Halmen, A.D. Luster, D.T. Golenbock, and M.W. Freeman Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways Nat. Med. 10 2004 416 421
5. S.G. Boaru, E. Borkham-Kamphorst, L. Tihaa, U. Haas, and R. Weiskirchen Expression analysis of inflammasomes in experimental models of inflammatory and fibrotic liver disease J. Inflamm. (Lond.) 9 2012 49
6. P.D. Cani, J. Amar, M.A. Iglesias, M. Poggi, C. Knauf, D. Bastelica, A.M. Neyrinck, F. Fava, K.M. Tuohy, and C. Chabo Metabolic endotoxemia initiates obesity and insulin resistance Diabetes 56 2007 1761 1772
7. A.M. Caricilli, P.H. Nascimento, J.R. Pauli, D.M. Tsukumo, L.A. Velloso, J.B. Carvalheira, and M.J. Saad Inhibition of toll-like receptor 2 expression improves insulin sensitivity and signaling in muscle and white adipose tissue of mice fed a high-fat diet J. Endocrinol. 199 2008 399 406
8. A.M. Caricilli, P.K. Picardi, L.L. de Abreu, M. Ueno, P.O. Prada, E.R. Ropelle, S.M. Hirabara, A. Castoldi, P. Vieira, and N.O. Camara Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice PLoS Biol. 9 2011 e1001212
9. T.B. Clarke, K.M. Davis, E.S. Lysenko, A.Y. Zhou, Y. Yu, and J.N. Weiser Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity Nat. Med. 16 2010 228 231
10. K.R. Coenen, M.L. Gruen, R.S. Lee-Young, M.J. Puglisi, D.H. Wasserman, and A.H. Hasty Impact of macrophage toll-like receptor 4 deficiency on macrophage infiltration into adipose tissue and the artery wall in mice Diabetologia 52 2009 318 328
11. T. Csak, M. Ganz, J. Pespisa, K. Kodys, A. Dolganiuc, and G. Szabo Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells Hepatology 54 2011 133 144
12. B. Dahlöf Cardiovascular disease risk factors: epidemiology and risk assessment Am. J. Cardiol. 105 1, Suppl 2010 3A 9A
13. J.E. Davis, N.K. Gabler, J. Walker-Daniels, and M.E. Spurlock Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat Obesity (Silver Spring) 16 2008 1248 1255
14. J. DeFuria, A.C. Belkina, M. Jagannathan-Bogdan, J. Snyder-Cappione, J.D. Carr, Y.R. Nersesova, D. Markham, K.J. Strissel, A.A. Watkins, and M. Zhu B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile Proc. Natl. Acad. Sci. USA 110 2013 5133 5138
15. D. De Nardo, and E. Latz NLRP3 inflammasomes link inflammation and metabolic disease Trends Immunol. 32 2011 373 379
16. W.K. den Dekker, C. Cheng, G. Pasterkamp, and H.J. Duckers Toll like receptor 4 in atherosclerosis and plaque destabilization Atherosclerosis 209 2010 314 320
17. Y. Ding, S. Subramanian, V.N. Montes, L. Goodspeed, S. Wang, C. Han, A.S. Teresa 3rd, J. Kim, K.D. O'Brien, and A. Chait Toll-like receptor 4 deficiency decreases atherosclerosis but does not protect against inflammation in obese low-density lipoprotein receptor-deficient mice Arterioscler. Thromb. Vasc. Biol. 32 2012 1596 1604
18. M.Y. Donath, and S.E. Shoelson Type 2 diabetes as an inflammatory disease Nat. Rev. Immunol. 11 2011 98 107
19. P. Duewell, H. Kono, K.J. Rayner, C.M. Sirois, G. Vladimer, F.G. Bauernfeind, G.S. Abela, L. Franchi, G. Nuñez, and M. Schnurr NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals Nature 464 2010 1357 1361
20. K. Eguchi, I. Manabe, Y. Oishi-Tanaka, M. Ohsugi, N. Kono, F. Ogata, N. Yagi, U. Ohto, M. Kimoto, and K. Miyake Saturated fatty acid and TLR signaling link β cell dysfunction and islet inflammation Cell Metab. 15 2012 518 533
21. J.A. Ehses, G. Lacraz, M.H. Giroix, F. Schmidlin, J. Coulaud, N. Kassis, J.C. Irminger, M. Kergoat, B. Portha, F. Homo-Delarche, and M.Y. Donath IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat Proc. Natl. Acad. Sci. USA 106 2009 13998 14003
22. J.A. Ehses, D.T. Meier, S. Wueest, J. Rytka, S. Boller, P.Y. Wielinga, A. Schraenen, K. Lemaire, S. Debray, and L. Van Lommel Toll-like receptor 2-deficient mice are protected from insulin resistance and beta cell dysfunction induced by a high-fat diet Diabetologia 53 2010 1795 1806
23. E. Elinav, T. Strowig, A.L. Kau, J. Henao-Mejia, C.A. Thaiss, C.J. Booth, D.R. Peaper, J. Bertin, S.C. Eisenbarth, J.I. Gordon, and R.A. Flavell NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis Cell 145 2011 745 757
24. M. Feuerer, L. Herrero, D. Cipolletta, A. Naaz, J. Wong, A. Nayer, J. Lee, A.B. Goldfine, C. Benoist, S. Shoelson, and D. Mathis Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters Nat. Med. 15 2009 930 939
25. B. Fève, and J.P. Bastard The role of interleukins in insulin resistance and type 2 diabetes mellitus Nat. Rev. Endocrinol. 5 2009 305 311
26. H. Fischer, P. Ellström, K. Ekström, L. Gustafsson, M. Gustafsson, and C. Svanborg Ceramide as a TLR4 agonist; a putative signalling intermediate between sphingolipid receptors for microbial ligands and TLR4 Cell. Microbiol. 9 2007 1239 1251
27. J.P. Furet, L.C. Kong, J. Tap, C. Poitou, A. Basdevant, J.L. Bouillot, D. Mariat, G. Corthier, J. Doré, and C. Henegar Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers Diabetes 59 2010 3049 3057
28. J. Gage, M. Hasu, M. Thabet, and S.C. Whitman Caspase-1 deficiency decreases atherosclerosis in apolipoprotein E-null mice Can. J. Cardiol. 28 2012 222 229
29. M.F. Gregor, and G.S. Hotamisligil Inflammatory mechanisms in obesity Annu. Rev. Immunol. 29 2011 415 445
30. T. Greiner, and F. Bäckhed Effects of the gut microbiota on obesity and glucose homeostasis Trends Endocrinol. Metab. 22 2011 117 123
31. U.K. Hanisch, T.V. Johnson, and J. Kipnis Toll-like receptors: roles in neuroprotection? Trends Neurosci. 31 2008 176 182
32. G.K. Hansson, and A. Hermansson The immune system in atherosclerosis Nat. Immunol. 12 2011 204 212
33. A.L. Harte, M.C. Varma, G. Tripathi, K.C. McGee, N.M. Al-Daghri, O.S. Al-Attas, S. Sabico, J.P. O'Hare, A. Ceriello, and P. Saravanan High fat intake leads to acute postprandial exposure to circulating endotoxin in type 2 diabetic subjects Diabetes Care 35 2012 375 382
34. J. Henao-Mejia, E. Elinav, C. Jin, L. Hao, W.Z. Mehal, T. Strowig, C.A. Thaiss, A.L. Kau, S.C. Eisenbarth, and M.J. Jurczak Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity Nature 482 2012 179 185
35. R.W. Himes, and C.W. Smith Tlr2 is critical for diet-induced metabolic syndrome in a murine model FASEB J. 24 2010 731 739
36. W.L. Holland, B.T. Bikman, L.P. Wang, G. Yuguang, K.M. Sargent, S. Bulchand, T.A. Knotts, G. Shui, D.J. Clegg, and M.R. Wenk Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice J. Clin. Invest. 121 2011 1858 1870
37. Y. Jiang, M. Wang, K. Huang, Z. Zhang, N. Shao, Y. Zhang, W. Wang, and S. Wang Oxidized low-density lipoprotein induces secretion of interleukin-1β by macrophages via reactive oxygen species-dependent NLRP3 inflammasome activation Biochem. Biophys. Res. Commun. 425 2012 121 126
38. C. Jin, and R.A. Flavell Molecular mechanism of NLRP3 inflammasome activation J. Clin. Immunol. 30 2010 628 631
39. H. Kanda, S. Tateya, Y. Tamori, K. Kotani, K. Hiasa, R. Kitazawa, S. Kitazawa, H. Miyachi, S. Maeda, K. Egashira, and M. Kasuga MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity J. Clin. Invest. 116 2006 1494 1505
40. T. Kawai, and S. Akira The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors Nat. Immunol. 11 2010 373 384
41. F. Kim, M. Pham, I. Luttrell, D.D. Bannerman, J. Tupper, J. Thaler, T.R. Hawn, E.W. Raines, and M.W. Schwartz Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity Circ. Res. 100 2007 1589 1596
42. A. Kleinridders, D. Schenten, A.C. Könner, B.F. Belgardt, J. Mauer, T. Okamura, F.T. Wunderlich, R. Medzhitov, and J.C. Brüning MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity Cell Metab. 10 2009 249 259
43. A.C. Könner, and J.C. Brüning Toll-like receptors: linking inflammation to metabolism Trends Endocrinol. Metab. 22 2011 16 23
44. L.H. Kuo, P.J. Tsai, M.J. Jiang, Y.L. Chuang, L. Yu, K.T. Lai, and Y.S. Tsai Toll-like receptor 2 deficiency improves insulin sensitivity and hepatic insulin signalling in the mouse Diabetologia 54 2011 168 179
45. M. Lamkanfi, and V.M. Dixit Inflammasomes and their roles in health and disease Annu. Rev. Cell Dev. Biol. 28 2012 137 161
46. N. Larsen, F.K. Vogensen, F.W. van den Berg, D.S. Nielsen, A.S. Andreasen, B.K. Pedersen, W.A. Al-Soud, S.J. Sørensen, L.H. Hansen, and M. Jakobsen Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults PLoS ONE 5 2010 e9085
47. L. Li, L. Chen, L. Hu, Y. Liu, H.Y. Sun, J. Tang, Y.J. Hou, Y.X. Chang, Q.Q. Tu, and G.S. Feng Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice Hepatology 54 2011 1620 1630
48. J. Liu, A. Divoux, J. Sun, J. Zhang, K. Clément, J.N. Glickman, G.K. Sukhova, P.J. Wolters, J. Du, and C.Z. Gorgun Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice Nat. Med. 15 2009 940 945
49. A.M. Lundberg, D.F. Ketelhuth, M.E. Johansson, N. Gerdes, S. Liu, M. Yamamoto, S. Akira, and G.K. Hansson Toll-like receptor 3 and 4 signalling through the TRIF and TRAM adaptors in haematopoietic cells promotes atherosclerosis Cardiovasc. Res. 2013 10.1093/cvr/cvt033
50. M. Madan, and S. Amar Toll-like receptor-2 mediates diet and/or pathogen associated atherosclerosis: proteomic findings PLoS ONE 3 2008 e3204 10.1371/journal.pone.0003204
51. S.L. Masters, A. Dunne, S.L. Subramanian, R.L. Hull, G.M. Tannahill, F.A. Sharp, C. Becker, L. Franchi, E. Yoshihara, and Z. Chen Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes Nat. Immunol. 11 2010 897 904
52. P. Menu, M. Pellegrin, J.F. Aubert, K. Bouzourene, A. Tardivel, L. Mazzolai, and J. Tschopp Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome Cell Death Dis. 2 2011 e137
53. K.S. Michelsen, M.H. Wong, P.K. Shah, W. Zhang, J. Yano, T.M. Doherty, S. Akira, T.B. Rajavashisth, and M. Arditi Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E Proc. Natl. Acad. Sci. USA 101 2004 10679 10684
54. L. Miele, V. Valenza, G. La Torre, M. Montalto, G. Cammarota, R. Ricci, R. Mascianà, A. Forgione, M.L. Gabrieli, and G. Perotti Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease Hepatology 49 2009 1877 1887
55. M. Milanski, G. Degasperi, A. Coope, J. Morari, R. Denis, D.E. Cintra, D.M. Tsukumo, G. Anhe, M.E. Amaral, and H.K. Takahashi Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity J. Neurosci. 29 2009 359 370
56. K. Miura, Y. Kodama, S. Inokuchi, B. Schnabl, T. Aoyama, H. Ohnishi, J.M. Olefsky, D.A. Brenner, and E. Seki Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice Gastroenterology 139 2010 323 334
57. A.E. Mullick, P.S. Tobias, and L.K. Curtiss Modulation of atherosclerosis in mice by Toll-like receptor 2 J. Clin. Invest. 115 2005 3149 3156
58. M.G. Netea, L.A. Joosten, E. Lewis, D.R. Jensen, P.J. Voshol, B.J. Kullberg, C.J. Tack, H. van Krieken, S.H. Kim, and A.F. Stalenhoef Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance Nat. Med. 12 2006 650 656
59. M.T. Nguyen, S. Favelyukis, A.K. Nguyen, D. Reichart, P.A. Scott, A. Jenn, R. Liu-Bryan, C.K. Glass, J.G. Neels, and J.M. Olefsky A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways J. Biol. Chem. 282 2007 35279 35292
60. J.K. Nicholson, E. Holmes, J. Kinross, R. Burcelin, G. Gibson, W. Jia, and S. Pettersson Host-gut microbiota metabolic interactions Science 336 2012 1262 1267
61. S. Nishimura, I. Manabe, M. Nagasaki, K. Eto, H. Yamashita, M. Ohsugi, M. Otsu, K. Hara, K. Ueki, and S. Sugiura CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity Nat. Med. 15 2009 914 920
62. J.S. Orr, M.J. Puglisi, K.L. Ellacott, C.N. Lumeng, D.H. Wasserman, and A.H. Hasty Toll-like receptor 4 deficiency promotes the alternative activation of adipose tissue macrophages Diabetes 61 2012 2718 2727
63. O. Osborn, H. Gram, E.P. Zorrilla, B. Conti, and T. Bartfai Insights into the roles of the inflammatory mediators IL-1, IL-18 and PGE2 in obesity and insulin resistance Swiss Med. Wkly. 138 2008 665 673
64. D. Pal, S. Dasgupta, R. Kundu, S. Maitra, G. Das, S. Mukhopadhyay, S. Ray, S.S. Majumdar, and S. Bhattacharya Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance Nat. Med. 2012 10.1038/nm.2851
65. M. Poggi, D. Bastelica, P. Gual, M.A. Iglesias, T. Gremeaux, C. Knauf, F. Peiretti, M. Verdier, I. Juhan-Vague, and J.F. Tanti C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet Diabetologia 50 2007 1267 1276
66. I. Presta, F. Andreozzi, E. Succurro, M.A. Marini, E. Laratta, R. Lauro, M.L. Hribal, F. Perticone, and G. Sesti IL-18 gene polymorphism and metabolic syndrome Nutr. Metab. Cardiovasc. Dis. 19 2009 e5 e6
67. J. Purohit, P. Hu, S.J. Burke, J.J. Collier, J. Chen, and L. Zhao The effects of NOD activation on adipocyte differentiation Obesity (Silver Spring) 2012 10.1038/oby.2012.155
68. P.J. Pussinen, A.S. Havulinna, M. Lehto, J. Sundvall, and V. Salomaa Endotoxemia is associated with an increased risk of incident diabetes Diabetes Care 34 2011 392 397
69. M.S. Radin, S. Sinha, B.A. Bhatt, N. Dedousis, and R.M. O'Doherty Inhibition or deletion of the lipopolysaccharide receptor Toll-like receptor-4 confers partial protection against lipid-induced insulin resistance in rodent skeletal muscle Diabetologia 51 2008 336 346
70. C.A. Rivera, P. Adegboyega, N. van Rooijen, A. Tagalicud, M. Allman, and M. Wallace Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis J. Hepatol. 47 2007 571 579
71. R. Roncon-Albuquerque Jr., M. Moreira-Rodrigues, B. Faria, A.P. Ferreira, C. Cerqueira, A.P. Lourenço, M. Pestana, P. von Hafe, and A.F. Leite-Moreira Attenuation of the cardiovascular and metabolic complications of obesity in CD14 knockout mice Life Sci. 83 2008 502 510
72. M. Saberi, N.B. Woods, C. de Luca, S. Schenk, J.C. Lu, G. Bandyopadhyay, I.M. Verma, and J.M. Olefsky Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice Cell Metab. 10 2009 419 429
73. G. Sabio, J. Cavanagh-Kyros, T. Barrett, D.Y. Jung, H.J. Ko, H. Ong, C. Morel, A. Mora, J. Reilly, J.K. Kim, and R.J. Davis Role of the hypothalamic-pituitary-thyroid axis in metabolic regulation by JNK1 Genes Dev. 24 2010 256 264
74. V.T. Samuel, and G.I. Shulman Mechanisms for insulin resistance: common threads and missing links Cell 148 2012 852 871
75. A.J. Sanyal, C. Campbell-Sargent, F. Mirshahi, W.B. Rizzo, M.J. Contos, R.K. Sterling, V.A. Luketic, M.L. Shiffman, and J.N. Clore Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities Gastroenterology 120 2001 1183 1192
76. J.D. Schertzer, A.K. Tamrakar, J.G. Magalhães, S. Pereira, P.J. Bilan, M.D. Fullerton, Z. Liu, G.R. Steinberg, A. Giacca, D.J. Philpott, and A. Klip NOD1 activators link innate immunity to insulin resistance Diabetes 60 2011 2206 2215
77. K. Schroder, and J. Tschopp The inflammasomes Cell 140 2010 821 832
78. T.A. Seimon, M.J. Nadolski, X. Liao, J. Magallon, M. Nguyen, N.T. Feric, M.L. Koschinsky, R. Harkewicz, J.L. Witztum, and S. Tsimikas Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress Cell Metab. 12 2010 467 482
79. J.J. Senn Toll-like receptor-2 is essential for the development of palmitate-induced insulin resistance in myotubes J. Biol. Chem. 281 2006 26865 26875
80. L. Serfaty, and M. Lemoine Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis Diabetes Metab. 34 2008 634 637
81. H. Shi, M.V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J.S. Flier TLR4 links innate immunity and fatty acid-induced insulin resistance J. Clin. Invest. 116 2006 3015 3025
82. A. Sourianarayanane, G. Garg, T.H. Smith, M.I. Butt, A.J. McCullough, and B. Shen Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease J. Crohns Colitis 2012 10.1016/j.crohns.2012.10.015
83. R. Stienstra, L.A. Joosten, T. Koenen, B. van Tits, J.A. van Diepen, S.A. van den Berg, P.C. Rensen, P.J. Voshol, G. Fantuzzi, and A. Hijmans The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity Cell Metab. 12 2010 593 605
84. L. Strandberg, M. Lorentzon, A. Hellqvist, S. Nilsson, V. Wallenius, C. Ohlsson, and J.O. Jansson Interleukin-1 system gene polymorphisms are associated with fat mass in young men J. Clin. Endocrinol. Metab. 91 2006 2749 2754
85. T. Suganami, T. Mieda, M. Itoh, Y. Shimoda, Y. Kamei, and Y. Ogawa Attenuation of obesity-induced adipose tissue inflammation in C3H/HeJ mice carrying a Toll-like receptor 4 mutation Biochem. Biophys. Res. Commun. 354 2007 45 49
86. O. Takeuchi, and S. Akira Pattern recognition receptors and inflammation Cell 140 2010 805 820
87. A.K. Tamrakar, J.D. Schertzer, T.T. Chiu, K.P. Foley, P.J. Bilan, D.J. Philpott, and A. Klip NOD2 activation induces muscle cell-autonomous innate immune responses and insulin resistance Endocrinology 151 2010 5624 5637
88. J.F. Tanti, F. Ceppo, J. Jager, and F. Berthou Implication of inflammatory signaling pathways in obesity-induced insulin resistance Front Endocrinol (Lausanne) 3 2012 181
89. M. Trøseid, I. Seljeflot, and H. Arnesen The role of interleukin-18 in the metabolic syndrome Cardiovasc. Diabetol. 9 2010 11
90. D.M. Tsukumo, M.A. Carvalho-Filho, J.B. Carvalheira, P.O. Prada, S.M. Hirabara, A.A. Schenka, E.P. Araújo, J. Vassallo, R. Curi, L.A. Velloso, and M.J. Saad Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance Diabetes 56 2007 1986 1998
91. P.J. Turnbaugh, R.E. Ley, M.A. Mahowald, V. Magrini, E.R. Mardis, and J.I. Gordon An obesity-associated gut microbiome with increased capacity for energy harvest Nature 444 2006 1027 1031
92. P.J. Turnbaugh, M. Hamady, T. Yatsunenko, B.L. Cantarel, A. Duncan, R.E. Ley, M.L. Sogin, W.J. Jones, B.A. Roe, and J.P. Affourtit A core gut microbiome in obese and lean twins Nature 457 2009 480 484
93. F. Usui, K. Shirasuna, H. Kimura, K. Tatsumi, A. Kawashima, T. Karasawa, S. Hida, J. Sagara, S. Taniguchi, and M. Takahashi Critical role of caspase-1 in vascular inflammation and development of atherosclerosis in Western diet-fed apolipoprotein E-deficient mice Biochem. Biophys. Res. Commun. 425 2012 162 168
94. B. Vandanmagsar, Y.H. Youm, A. Ravussin, J.E. Galgani, K. Stadler, R.L. Mynatt, E. Ravussin, J.M. Stephens, and V.D. Dixit The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance Nat. Med. 17 2011 179 188
95. M. Vijay-Kumar, J.D. Aitken, F.A. Carvalho, T.C. Cullender, S. Mwangi, S. Srinivasan, S.V. Sitaraman, R. Knight, R.E. Ley, and A.T. Gewirtz Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5 Science 328 2010 228 231
96. M. Vives-Pi, N. Somoza, J. Fernández-Alvarez, F. Vargas, P. Caro, A. Alba, R. Gomis, M.O. Labeta, and R. Pujol-Borrell Evidence of expression of endotoxin receptors CD14, toll-like receptors TLR4 and TLR2 and associated molecule MD-2 and of sensitivity to endotoxin (LPS) in islet beta cells Clin. Exp. Immunol. 133 2003 208 218
97. G.I. Vladimer, D. Weng, S.W. Paquette, S.K. Vanaja, V.A. Rathinam, M.H. Aune, J.E. Conlon, J.J. Burbage, M.K. Proulx, and Q. Liu The NLRP12 inflammasome recognizes Yersinia pestis Immunity 37 2012 96 107
98. S.P. Weisberg, D. Hunter, R. Huber, J. Lemieux, S. Slaymaker, K. Vaddi, I. Charo, R.L. Leibel, and A.W. Ferrante Jr. CCR2 modulates inflammatory and metabolic effects of high-fat feeding J. Clin. Invest. 116 2006 115 124
99. H. Wen, D. Gris, Y. Lei, S. Jha, L. Zhang, M.T. Huang, W.J. Brickey, and J.P. Ting Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling Nat. Immunol. 12 2011 408 415
100. X.Z. West, N.L. Malinin, A.A. Merkulova, M. Tischenko, B.A. Kerr, E.C. Borden, E.A. Podrez, R.G. Salomon, and T.V. Byzova Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands Nature 467 2010 972 976
101. S. Winer, Y. Chan, G. Paltser, D. Truong, H. Tsui, J. Bahrami, R. Dorfman, Y. Wang, J. Zielenski, and F. Mastronardi Normalization of obesity-associated insulin resistance through immunotherapy Nat. Med. 15 2009 921 929
102. D.A. Winer, S. Winer, L. Shen, P.P. Wadia, J. Yantha, G. Paltser, H. Tsui, P. Wu, M.G. Davidson, and M.N. Alonso B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies Nat. Med. 17 2011 610 617
103. World Health Organization. (2013). Fact sheets. http://www.who.int/ mediacentre/factsheets/.
104. D. Wu, A.B. Molofsky, H.E. Liang, R.R. Ricardo-Gonzalez, H.A. Jouihan, J.K. Bando, A. Chawla, and R.M. Locksley Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis Science 332 2011 243 247
105. X. Zhang, G. Zhang, H. Zhang, M. Karin, H. Bai, and D. Cai Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity Cell 135 2008 61 73
106. L. Zhao, P. Hu, Y. Zhou, J. Purohit, and D. Hwang NOD1 activation induces proinflammatory gene expression and insulin resistance in 3T3-L1 adipocytes Am. J. Physiol. Endocrinol. Metab. 301 2011 E587 E598
107. R. Zhou, A. Tardivel, B. Thorens, I. Choi, and J. Tschopp Thioredoxin-interacting protein links oxidative stress to inflammasome activation Nat. Immunol. 11 2010 136 140